Qiming Venture Partners Wishes You a Prosperous Year of the Horse

A bountiful new year, all things made new.

Qiming Venture Partners wishes you a prosperous Year of the Horse (Bingwu)

Recently, Qiming Venture Partners launched two limited-edition red envelope covers for the Year of the Horse

Click "Read Original" at the end of this article to claim yours

And receive the usage guide

Meanwhile, long-press to save the matching poster below

Feel free to share!

Design 1: Qiji Welcoming Spring

Design 2: Fortune Begins

Past Highlights

Five AI IPOs in Seven Months, Qiming Venture Partners: Investing in AI Is the Greatest Certainty in Chinese Investing for the Next Two Decades

Get Your Red Envelopes Now | Qiming Venture Partners Year of the Horse Limited-Edition Red Envelope Covers Giveaway!

Qiming Honors | Five Qiming Venture Partners Investors Named to 2025 Forbes China Midas List

Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.

To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. More than 80 portfolio companies have become recognized unicorns or super-unicorns.

Many companies in Qiming Venture Partners' portfolio have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 00800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Sinocelltech (688520.SH), Insilico Medicine (03696.HK), Argo Biopharma, MedCircle, MediLink Therapeutics, LaNova Medicines, StepFun, and others.

Qiming Honors | Qiming Venture Partners Wins Eight Awards Including Third Place in Zero2IPO's 2025 China Venture Capital Rankings